This compound is a protected amino acid derivative commonly employed as a peptide building block in solid-phase peptide synthesis. It features a fluorenylmethoxycarbonyl (Fmoc) protecting group and a methyl ether substituent on the threonine side chain, facilitating the construction of modified peptide sequences.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 928063-81-4
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methylbutanoic acid
pharmaceutical intermediate
Fmoc-D-Valine
pharmaceutical intermediate
Fmoc-O-tert-butyl-D-threonine
pharmaceutical intermediate
Fmoc-O-tert-Butyl-L-threonine
research compound
(S)-2-(Benzyloxycarbonylamino)-2-phenylacetic acid
pharmaceutical intermediate
1-(3,5-Dichlorophenyl)-1-propanone
pharmaceutical intermediate
4-(4-Fluorobenzyl)piperidine hydrochloride
pharmaceutical intermediate
7-Benzyloxyindole-3-carbaldehyde
pharmaceutical intermediate
(2S,3R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methoxybutanoic acid
BOGQZFFOTLSMMA-XIKOKIGWSA-N
C[C@H]([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)OC